Short-Term Outcomes of Patients Undergoing Portal Vein Embolization: an ACS-NSQIP Procedure-Targeted Hepatectomy Analysis

Fabio Bagante,Gaya Spolverato,Elizabeth M. Gleeson,Katiuscha Merath,Aslam Ejaz,Jordan M. Cloyd,Allan Tsung,Mary Dillhoff,Henry A. Pitt,Timothy M. Pawlik

Short-Term Outcomes of Patients Undergoing Portal Vein Embolization: an ACS-NSQIP Procedure-Targeted Hepatectomy Analysis

2019

Fabio Bagante
Gaya Spolverato
Elizabeth M. Gleeson
Katiuscha Merath
Aslam Ejaz
Jordan M. Cloyd
Allan Tsung
Mary Dillhoff
Henry A. Pitt
Timothy M. Pawlik

Background Preoperative portal vein embolization (PVE) is utilized to induce growth of the future liver remnant volume (FLRV) among patients at elevated risk of post-hepatectomy liver failure (PHLF).

Keywords:

Surgery
Portal vein embolization
Hepatectomy
Medicine
increased risk
biliary leak
acs nsqip
liver failure
Propensity score matching
bile leak

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations